US Bancorp
CRGX

US Bancorp’s CARGO Therapeutics CRGX Stock Holding History

US Bancorp’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51
Closed -$735 – 4233
2024
Q4 		$735 Sell
51
-55
-52% -$998 ﹤0.01% 3992
2024
Q3 		$1.96K Sell
106
-121
-53% -$2.17K ﹤0.01% 3791
2024
Q2 		$3.73K Buy
+227
New +$4.32K ﹤0.01% 3590

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

US Bancorp's CRGX Position: Q1 2025 in Review

US Bancorp sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 51 shares — an estimated $735 sold.

US Bancorp first reported a position in CRGX in Q2 2024 and held it in 3 quarters. The position peaked at $3.73K in Q2 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • US Bancorp reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 51 CARGO Therapeutics shares in Q1 2025, an estimated $735.
  • US Bancorp first reported a position in CARGO Therapeutics in Q2 2024 and held it in 3 quarters.
  • US Bancorp's CARGO Therapeutics position peaked at $3.73K in Q2 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.